ClinicalTrials.Veeva

Menu

Comparison of Two Vaginal Mesh Kits in the Management of Vaginal Prolapse (ELEPE)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Vaginal Prolapse

Treatments

Device: Perigee™
Device: Elevate Ant™

Study type

Observational

Funder types

Other

Identifiers

NCT03187574
69HCL17_0356

Details and patient eligibility

About

Our study is a non-randomized prospective study compared two groups matched for anterior/apical POP-Q grade: 84 received Elevate Ant™ single-incision mesh (group A) and 42 Perigee™ transvaginal mesh (group B). The study hypothesis was that the Elevate Ant™ mesh would provide better apical correction than the Perigee™ mesh. One- and 2-year follow-up comprised anatomic assessment (POP-Q) and QoL (PFDI-20, PFIQ-7, PISQ-12). Success was defined as 2-year POP-Q ≤1. Secondary endpoints were function and complications.

Enrollment

126 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • symptomatic patient presenting with POP-Q grade ≥3 anterior or apical prolapse

Trial design

126 participants in 2 patient groups

Group A
Description:
group received Elevate Ant™ single-incision mesh
Treatment:
Device: Elevate Ant™
Group B
Description:
group received Perigee™ transvaginal mesh
Treatment:
Device: Perigee™

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems